RegenMed Circles

𝐖𝐡𝐲 𝐘𝐨𝐮 𝐒𝐡𝐨𝐮𝐥𝐝 𝐂𝐨𝐧𝐬𝐢𝐝𝐞𝐫 𝐈𝐧𝐯𝐞𝐬𝐭𝐢𝐧𝐠 𝐈𝐧 𝐑𝐞𝐠𝐞𝐧𝐌𝐞𝐝 If you are a healthcare professional, you know the value of your clinical observations. You know the quality of your engagement with patients. You know your desire to prove or disprove treatment hypotheses. You realize how broken healthcare is.    RegenMed invests in you and your peers. It helps you transform your everyday clinical work into validated and clinically significant datasets. Datasets which you can own, which we help you license. Datasets where you share in the license fees. You know how valuable those datasets can be. We would be honored if you joined us as a shareholder.  Invest now: https://lnkd.in/ebFneQyT 𝘖𝘶𝘳 𝘙𝘦𝘨 𝘊𝘍 𝘰𝘧𝘧𝘦𝘳𝘪𝘯𝘨 𝘪𝘴 𝘮𝘢𝘥𝘦 𝘢𝘷𝘢𝘪𝘭𝘢𝘣𝘭𝘦 𝘵𝘩𝘳𝘰𝘶𝘨𝘩 𝘚𝘵𝘢𝘳𝘵𝘌𝘯𝘨𝘪𝘯𝘦 𝘗𝘳𝘪𝘮𝘢𝘳𝘺, 𝘓𝘓𝘊. 𝘛𝘩𝘪𝘴 𝘪𝘯𝘷𝘦𝘴𝘵𝘮𝘦𝘯𝘵 𝘪𝘴 𝘴𝘱𝘦𝘤𝘶𝘭𝘢𝘵𝘪𝘷𝘦, 𝘪𝘭𝘭𝘪𝘲𝘶𝘪𝘥, 𝘢𝘯𝘥 𝘪𝘯𝘷𝘰𝘭𝘷𝘦𝘴 𝘢 𝘩𝘪𝘨𝘩 𝘥𝘦𝘨𝘳𝘦𝘦 𝘰𝘧 𝘳𝘪𝘴𝘬, 𝘪𝘯𝘤𝘭𝘶𝘥𝘪𝘯𝘨 𝘵𝘩𝘦 𝘱𝘰𝘴𝘴𝘪𝘣𝘭𝘦 𝘭𝘰𝘴𝘴 𝘰𝘧 𝘺𝘰𝘶𝘳 𝘦𝘯𝘵𝘪𝘳𝘦 𝘪𝘯𝘷𝘦𝘴𝘵𝘮𝘦𝘯𝘵.

𝐀𝐭𝐭𝐞𝐧𝐭𝐢𝐨𝐧 𝐒𝐡𝐨𝐜𝐤𝐰𝐚𝐯𝐞 𝐏𝐫𝐚𝐜𝐭𝐢𝐭𝐢𝐨𝐧𝐞𝐫𝐬. Are you ready to improve your patient outcomes and unlock new revenue streams? The fast-growing $3 billion shockwave market is a good place to start. As demand for non-surgical therapeutic options surges, the need for robust clinical evidence is more critical than ever. Introducing 𝐏𝐡𝐲𝐬𝐢𝐜𝐢𝐚𝐧𝐬-𝐎𝐰𝐧𝐞𝐝 𝐂𝐢𝐫𝐜𝐥𝐞𝐬 (POCs) — the innovative platform designed to streamline the capture, aggregation, and licensing of high-quality, real-world shockwave data. With minimal cost and time commitments, you can focus on what you do best — providing exceptional care to your patients. 𝐖𝐡𝐚𝐭’𝐬 𝐈𝐧 𝐈𝐭 𝐅𝐨𝐫 𝐏𝐎𝐂 𝐌𝐞𝐦𝐛𝐞𝐫𝐬? 𝐌𝐨𝐧𝐞𝐭𝐢𝐳𝐞 𝐘𝐨𝐮𝐫 𝐄𝐱𝐩𝐞𝐫𝐭𝐢𝐬𝐞: Qualifying Principal Investigators earn 10% of resulting license fees, while Investigators share 75%. 𝐘𝐨𝐮𝐫 𝐃𝐚𝐭𝐚, 𝐘𝐨𝐮𝐫 𝐂𝐨𝐧𝐭𝐫𝐨𝐥: The data you collect is yours to use for various non-commercial purposes. 𝐒𝐮𝐩𝐩𝐨𝐫𝐭 𝐭𝐡𝐞 𝐅𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐒𝐡𝐨𝐜𝐤𝐰𝐚𝐯𝐞 𝐓𝐡𝐞𝐫𝐚𝐩𝐲: Help shape the next generation of shockwave devices and applications by contributing valuable clinical insights. Join your peers in advancing the field of shockwave therapy while enhancing your practice's profitability! Ready to get started? Click the link below to complete your form and become a part of this groundbreaking initiative! Join Now: https://hubs.li/Q0308chC0

𝐑𝐞𝐠𝐞𝐧𝐌𝐞𝐝 𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐓𝐡𝐞𝐬𝐞𝐬 𝐖𝐞𝐛𝐢𝐧𝐚𝐫 𝐑𝐞𝐜𝐨𝐫𝐝𝐢𝐧𝐠 𝐍𝐨𝐰 𝐀𝐯𝐚𝐢𝐥𝐚𝐛𝐥𝐞 On November 12, RegenMed’s CEO and Co-Founder Michael P. Tierney conducted a webinar discussing the Company’s investment theses and global traction.  The webinar recording has been divided into ten chapters, now available on the Company’s Investors Page: https://lnkd.in/ebFneQyT

Proud to partner with such innovative minds!  #RWDCircles #RegenMedClients #CirclesUseCases

Whether you are a physician interested in earning license revenues from Real-World Evidence datasets, or want to learn more about the current RegenMed investment opportunity, this webinar will be of interest.  You can register here: https://lnkd.in/emk_8iFM 𝘛𝘩𝘪𝘴 𝘙𝘦𝘨 𝘊𝘍 𝘰𝘧𝘧𝘦𝘳𝘪𝘯𝘨 𝘪𝘴 𝘮𝘢𝘥𝘦 𝘢𝘷𝘢𝘪𝘭𝘢𝘣𝘭𝘦 𝘵𝘩𝘳𝘰𝘶𝘨𝘩 𝘚𝘵𝘢𝘳𝘵𝘌𝘯𝘨𝘪𝘯𝘦 𝘗𝘳𝘪𝘮𝘢𝘳𝘺 𝘓𝘓𝘊, 𝘮𝘦𝘮𝘣𝘦𝘳 𝘍𝘐𝘕𝘙𝘈/𝘚𝘐𝘗𝘊. 𝘛𝘩𝘪𝘴 𝘪𝘯𝘷𝘦𝘴𝘵𝘮𝘦𝘯𝘵 𝘪𝘴 𝘴𝘱𝘦𝘤𝘶𝘭𝘢𝘵𝘪𝘷𝘦, 𝘪𝘭𝘭𝘪𝘲𝘶𝘪𝘥, 𝘢𝘯𝘥 𝘪𝘯𝘷𝘰𝘭𝘷𝘦𝘴 𝘢 𝘩𝘪𝘨𝘩 𝘥𝘦𝘨𝘳𝘦𝘦 𝘰𝘧 𝘳𝘪𝘴𝘬, 𝘪𝘯𝘤𝘭𝘶𝘥𝘪𝘯𝘨 𝘵𝘩𝘦 𝘱𝘰𝘴𝘴𝘪𝘣𝘭𝘦 𝘭𝘰𝘴𝘴 𝘰𝘧 𝘺𝘰𝘶𝘳 𝘦𝘯𝘵𝘪𝘳𝘦 𝘪𝘯𝘷𝘦𝘴𝘵𝘮𝘦𝘯𝘵.

𝐂𝐨𝐧𝐬𝐢𝐝𝐞𝐫𝐢𝐧𝐠 𝐈𝐧𝐯𝐞𝐬𝐭𝐢𝐧𝐠 𝐢𝐧 𝐚 𝐒𝐭𝐚𝐫𝐭𝐮𝐩? 𝐂𝐨𝐧𝐬𝐢𝐝𝐞𝐫 𝐭𝐡𝐢𝐬. Investing in innovative startups not only offers the potential for high returns but also gives you a chance to be part of ideas that can change the world. Find out more: https://lnkd.in/e-vpyVZn

𝐋𝐢𝐯𝐞-𝐬𝐭𝐫𝐞𝐚𝐦𝐞𝐝 𝐈𝐧𝐯𝐞𝐬𝐭𝐨𝐫𝐬 𝐖𝐞𝐛𝐢𝐧𝐚𝐫 "𝐄𝐱𝐩𝐞𝐜𝐭𝐚𝐭𝐢𝐨𝐧𝐬 𝟐𝟎𝟐𝟓" Please join us for RegenMed, Inc. Investors Webinar, Monday, December 16 at 6:30 PM, New York time. RegenMed's CEO Michael P Tierney will review the Company's momentum through the end of the year, as well as expectations for 2025. For more information, see our Investors Page: https://lnkd.in/ebFneQyT Register here: https://lnkd.in/dTpjzcSK 𝘛𝘩𝘪𝘴 𝘙𝘦𝘨 𝘊𝘍 𝘰𝘧𝘧𝘦𝘳𝘪𝘯𝘨 𝘪𝘴 𝘮𝘢𝘥𝘦 𝘢𝘷𝘢𝘪𝘭𝘢𝘣𝘭𝘦 𝘵𝘩𝘳𝘰𝘶𝘨𝘩 𝘚𝘵𝘢𝘳𝘵𝘌𝘯𝘨𝘪𝘯𝘦 𝘗𝘳𝘪𝘮𝘢𝘳𝘺 𝘓𝘓𝘊, 𝘮𝘦𝘮𝘣𝘦𝘳 𝘍𝘐𝘕𝘙𝘈/𝘚𝘐𝘗𝘊. 𝘛𝘩𝘪𝘴 𝘪𝘯𝘷𝘦𝘴𝘵𝘮𝘦𝘯𝘵 𝘪𝘴 𝘴𝘱𝘦𝘤𝘶𝘭𝘢𝘵𝘪𝘷𝘦, 𝘪𝘭𝘭𝘪𝘲𝘶𝘪𝘥, 𝘢𝘯𝘥 𝘪𝘯𝘷𝘰𝘭𝘷𝘦𝘴 𝘢 𝘩𝘪𝘨𝘩 𝘥𝘦𝘨𝘳𝘦𝘦 𝘰𝘧 𝘳𝘪𝘴𝘬, 𝘪𝘯𝘤𝘭𝘶𝘥𝘪𝘯𝘨 𝘵𝘩𝘦 𝘱𝘰𝘴𝘴𝘪𝘣𝘭𝘦 𝘭𝘰𝘴𝘴 𝘰𝘧 𝘺𝘰𝘶𝘳 𝘦𝘯𝘵𝘪𝘳𝘦 𝘪𝘯𝘷𝘦𝘴𝘵𝘮𝘦𝘯𝘵.

𝐄𝐱𝐜𝐢𝐭𝐢𝐧𝐠 𝐍𝐞𝐰𝐬 𝐟𝐫𝐨𝐦 𝐑𝐞𝐠𝐞𝐧𝐌𝐞𝐝! Our recent webinar dove into our investment theses and the groundbreaking work in addressable markets totaling +$𝟏 𝐭𝐫𝐢𝐥𝐥𝐢𝐨𝐧. RegenMed is an established, revenue-producing company with a global client base, growing product adoption, and significant competitive advantages. But more than that, we’re disrupting the healthcare data industry in a way which will lead to better health outcomes for all. A total of ten self-contained segments from that webinar can be viewed on the Company’s Investors Page: https://lnkd.in/ebFneQyT

𝐓𝐡𝐞 𝐏𝐨𝐰𝐞𝐫 𝐨𝐟 𝐆𝐫𝐨𝐰𝐢𝐧𝐠 𝐑𝐞𝐜𝐮𝐫𝐫𝐢𝐧𝐠 𝐒𝐚𝐚𝐒 𝐑𝐞𝐯𝐞𝐧𝐮𝐞𝐬 𝐈𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 At RegenMed, we believe that the best companies are those that can create and expand recurring revenues across a diverse client base. In a healthcare landscape that can be unpredictable, our approach sets us apart. With a vast market size in the U.S. alone, the healthcare industry offers countless opportunities. However, it's essential to recognize the challenges faced by pre-revenue companies trying to innovate. Did you know that only 14% of drugs and vaccines entering #clinicaltrials receive regulatory approval? It's a tough road for many! What makes RegenMed unique? We provide essential tools needed by medical providers and product manufacturers to conduct #clinicalstudies. Our patented product, Circles, is designed to meet those crucial needs. With a strong product-market fit and a commitment to monthly subscriptions, our revenue model allows for rapid scalability while keeping costs accessible for clients. Led by an experienced management team, we prioritize steady growth, cash earnings, and minimizing debt – because we know that in the world of healthcare, slow and steady wins the race. Join us on this journey as we transform the healthcare: https://hubs.li/Q02ZMlwz0 𝘛𝘩𝘪𝘴 𝘙𝘦𝘨 𝘊𝘍 𝘰𝘧𝘧𝘦𝘳𝘪𝘯𝘨 𝘪𝘴 𝘮𝘢𝘥𝘦 𝘢𝘷𝘢𝘪𝘭𝘢𝘣𝘭𝘦 𝘵𝘩𝘳𝘰𝘶𝘨𝘩 𝘚𝘵𝘢𝘳𝘵𝘌𝘯𝘨𝘪𝘯𝘦 𝘗𝘳𝘪𝘮𝘢𝘳𝘺, 𝘓𝘓𝘊. 𝘛𝘩𝘪𝘴 𝘪𝘯𝘷𝘦𝘴𝘵𝘮𝘦𝘯𝘵 𝘪𝘴 𝘴𝘱𝘦𝘤𝘶𝘭𝘢𝘵𝘪𝘷𝘦, 𝘪𝘭𝘭𝘪𝘲𝘶𝘪𝘥, 𝘢𝘯𝘥 𝘪𝘯𝘷𝘰𝘭𝘷𝘦𝘴 𝘢 𝘩𝘪𝘨𝘩 𝘥𝘦𝘨𝘳𝘦𝘦 𝘰𝘧 𝘳𝘪𝘴𝘬, 𝘪𝘯𝘤𝘭𝘶𝘥𝘪𝘯𝘨 𝘵𝘩𝘦 𝘱𝘰𝘴𝘴𝘪𝘣𝘭𝘦 𝘭𝘰𝘴𝘴 𝘰𝘧 𝘺𝘰𝘶𝘳 𝘦𝘯𝘵𝘪𝘳𝘦 𝘪𝘯𝘷𝘦𝘴𝘵𝘮𝘦𝘯𝘵.

Did you know that 𝐨𝐯𝐞𝐫 𝟒𝟗𝟏,𝟎𝟎𝟎 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐬𝐭𝐮𝐝𝐢𝐞𝐬 are currently underway worldwide? As the demand for innovative drugs, biologics, and medical devices rises, the importance of efficient data collection tools has never been greater. 📈 At 𝐑𝐞𝐠𝐞𝐧𝐌𝐞𝐝, we’re at the forefront of this transformation. Our unique platform, 𝐂𝐢𝐫𝐜𝐥𝐞𝐬, empowers individual physicians and industry leaders alike to conduct regulatorily compliant #clinicalstudies with ease. We’re not just equipping healthcare data miners with the tools they need; we’re ensuring they 𝐦𝐨𝐧𝐞𝐭𝐢𝐳𝐞 𝐭𝐡𝐞𝐢𝐫 𝐞𝐟𝐟𝐨𝐫𝐭𝐬 effectively. This is your opportunity to be part of a thriving ecosystem that's shaping the future of healthcare. Join us as we redefine #clinicaltrials and pave the way for innovation: https://lnkd.in/eZ8RVzPz